The University of British Columbia;Universitat Hamburg
发明人:
Medhi Mike Khankischpur,Olga Petina,Detlef Geffken,Dagmar Ernhoefer,Michael Hayden
申请号：
GB201615541
公开号：
GB2544385A
申请日:
2015.02.14
申请国别(地区):
GB
年份:
2017
代理人:
摘要：
The current application relates to a pharmaceutical composition for the treatment or amelioration of a neurological disease, wherein the composition comprises a therapeutically effective amount of a caspase-6 inhibitor which is an arylpropynamide derivative. The composition can be formulated for oral or topical administration, subcutaneous, intravenous, or intramuscular injection, infusion, inhalation, or intrthecal injection.
